New therapeutic agents for the treatment of bone diseases.

New therapeutic agents for the treatment of bone diseases.

Item
http://www.wikidata.org/entity/Q36161232
Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat storesCorticosteroids in brain cancer patients: benefits and pitfalls.Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice.Non-Ototoxic Local Delivery of Bisphosphonate to the Mammalian Cochlea.Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate markerNanotechnology in the targeted drug delivery for bone diseases and bone regeneration.Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate compositeZoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner.Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication-Related Osteonecrosis of the Jaw in a Rat Model
P2860

New therapeutic agents for the treatment of bone diseases.

Item
http://www.wikidata.org/entity/Q36161232
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
New therapeutic agents for the treatment of bone diseases.
@ast
New therapeutic agents for the treatment of bone diseases.
@en
type
label
New therapeutic agents for the treatment of bone diseases.
@ast
New therapeutic agents for the treatment of bone diseases.
@en
prefLabel
New therapeutic agents for the treatment of bone diseases.
@ast
New therapeutic agents for the treatment of bone diseases.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
New therapeutic agents for the treatment of bone diseases.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698